Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,644.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 3,170.00
  • 52 Week Low: 1,586.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 298,293
  • Market Cap: £1,759.27m
  • RiskGrade: 128
  • Beta: 0.01

Regulatory News

Director/PDMR Shareholding 13-Apr-2026 17:59 RNS
Director/PDMR Shareholding 01-Apr-2026 09:40 RNS
Notification of Major Holdings 10-Mar-2026 15:56 RNS
Notification of Major Holdings 10-Mar-2026 15:56 RNS
Director/PDMR Shareholding 04-Mar-2026 10:33 RNS
Director Declaration 04-Mar-2026 10:08 RNS
Director/PDMR Shareholding 27-Feb-2026 12:48 RNS
Amundi Smart Overnight Return UCITS ETF GBP Hedg... 12-Feb-2026 20:06 EQS Group
Interim Results 26-Feb-2026 07:00 RNS
Block Listing Return 02-Feb-2026 12:39 RNS
Total Voting Rights 02-Feb-2026 11:21 RNS
Successful formation of Chinese porcine JV 02-Feb-2026 07:00 RNS
PRP Regulatory Progress – Canada 23-Jan-2026 17:23 RNS
Half Year Trading Update – Ahead of expect... 16-Jan-2026 07:00 RNS
Director/PDMR Shareholding 27-Nov-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,644.00p
Change Today -2.00p
% Change -0.08 %
52 Week High 3,170.00
52 Week Low 1,586.00
Volume 298,293
Shares Issued 66.54m
Market Cap £1,759.27m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 17-Apr-2026

Time Volume / Share Price
16:35 378 @ 2,644.00p
16:35 114 @ 2,644.00p
16:35 51,762 @ 2,644.00p
16:35 61 @ 2,644.00p
16:35 417 @ 2,644.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page